Table 2.
Study | Duration | Design | Size | Inclusion Criteria | Comparator Group | Treatment Delays | Diabetes Mellitus | OHCA | Cardiogenic Shock | In-Hospital Mortality | Other Key Findings |
---|---|---|---|---|---|---|---|---|---|---|---|
International COVID-ACS Registry Kite et al,23 2021 |
March 2020 – July 2020 | Prospective, multicenter, international | 144 STEMI, 121 NSTE-ACS | Only if underwent invasive angiography | Pre-COVID-19 BCIS and MINAP databases | Yes | 36% | STEMI: 9% NSTE-ACS: 1% |
STEMI: 20% NSTE-ACS: 5% |
STEMI:23% NSTE-ACS: 7% |
|
NACMI Registry Garcia et al,28 2021 |
January 2020 – December 2020 | Prospective, multicenter, United States & Canada | 230 STEMI | Invasive angiography and medically managed patients | Historical propensity-matched cohort from Midwest STEMI Consortium | Yes | 46% | 11% | 18% | 33% |
|
Spanish Infarct Code Registry Rodriguez-Leor et al,30 2021 |
March 2020 – April 2020 | Retrospective, multicenter, Spain | 91 STEMI | Invasive angiography and medically managed patients | Contemporary COVID-19–negative controls | No | 23% | 8% | 10% | 23% |
|
MINAP registry Rashid et al,29 2021 |
March 2020 – May 2020 | Retrospective, multicenter, England | 153 STEMI, 311 NSTE-ACS | Angiography and medically managed patients | Contemporary COVID-19 negative controls | Yes | 38% | Combined STEMI/NSTE-ACS: 4% | Combined STEMI/NSTE-ACS: 10% | Combined STEMI/NSTE-ACS: 24% |
|
Abbreviations: ACS, acute coronary syndrome; BCIS, British Cardiovascular Intervention Society; MINAP, Myocardial Ischaemia National Audit Project; NACMI, North American COVID-19 Myocardial Infarction; NSTE-ACS, non–ST-elevation acute coronary syndrome; OHCA, out-of-hospital cardiac arrest; STEMI, ST-elevation myocardial infarction.